| pubmed-article:1333136 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1333136 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
| pubmed-article:1333136 | lifeskim:mentions | umls-concept:C0005795 | lld:lifeskim |
| pubmed-article:1333136 | lifeskim:mentions | umls-concept:C0750484 | lld:lifeskim |
| pubmed-article:1333136 | lifeskim:mentions | umls-concept:C0032520 | lld:lifeskim |
| pubmed-article:1333136 | lifeskim:mentions | umls-concept:C1446409 | lld:lifeskim |
| pubmed-article:1333136 | lifeskim:mentions | umls-concept:C0020985 | lld:lifeskim |
| pubmed-article:1333136 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1333136 | pubmed:dateCreated | 1992-12-29 | lld:pubmed |
| pubmed-article:1333136 | pubmed:abstractText | In a series of 385 sera obtained from volunteer blood donors positive for the first-generation hepatitis C virus assay (Ortho), the viral genome was detected by polymerase chain reaction (PCR) in 89 sera (23%). Most PCR-positive sera were found positive with the c100-3 neutralisation assay (Abbott) and by two second-generation enzyme immunoassays (Abbott, Ortho). However overall specificity of these assays was rather low. By immunoblotting (Innogenetics and Chiron/Ortho) the specificity could be considerably improved and the best correlation with carrier state was obtained when analysing the results for lane-specific reaction: all 89 viral carriers and only 9 other donors had antibodies against structural 'core' epitopes. From the present data we can conclude that in screening a volunteer blood donor population the confirmation of antibodies against 'core' epitopes by immunoblotting is strongly associated with viral carriage. | lld:pubmed |
| pubmed-article:1333136 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1333136 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1333136 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1333136 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1333136 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1333136 | pubmed:issn | 0042-9007 | lld:pubmed |
| pubmed-article:1333136 | pubmed:author | pubmed-author:VermylenCC | lld:pubmed |
| pubmed-article:1333136 | pubmed:author | pubmed-author:ClaeysHH | lld:pubmed |
| pubmed-article:1333136 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:1333136 | pubmed:author | pubmed-author:VerhaertHH | lld:pubmed |
| pubmed-article:1333136 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1333136 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:1333136 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1333136 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1333136 | pubmed:pagination | 198-203 | lld:pubmed |
| pubmed-article:1333136 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:meshHeading | pubmed-meshheading:1333136-... | lld:pubmed |
| pubmed-article:1333136 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1333136 | pubmed:articleTitle | Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction. | lld:pubmed |
| pubmed-article:1333136 | pubmed:affiliation | Belgian Red Cross Blood Transfusion Centre, Leuven. | lld:pubmed |
| pubmed-article:1333136 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1333136 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1333136 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1333136 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1333136 | lld:pubmed |
